Hippo-Independent Activation of YAP by the GNAQ Uveal Melanoma Oncogene through a Trio-Regulated Rho GTPase Signaling Circuitry-Reference-Cited by-同舟云学术

Hippo-Independent Activation of YAP by the GNAQ Uveal Melanoma Oncogene through a Trio-Regulated Rho GTPase Signaling Circuitry

Published:2014-06 Issue:6 Volume:25 Page:831-845
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Feng Xiaodong,Degese Maria Sol,Iglesias-Bartolome Ramiro,Vaque Jose P.,Molinolo Alfredo A.,Rodrigues Murilo,Zaidi M. Raza,Ksander Bruce R.,Merlino Glenn,Sodhi Akrit,Chen Qianming,Gutkind J. Silvio

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference56 articles.

1. Serum deprivation inhibits the transcriptional co-activator YAP and cell growth via phosphorylation of the 130-kDa isoform of Angiomotin by the LATS1/2 protein kinases;Adler;Proc. Natl. Acad. Sci. U S A,2013

2. A mechanical checkpoint controls multicellular growth through YAP/TAZ regulation by actin-processing factors;Aragona;Cell,2013

3. Treatment of choroidal melanoma using photodynamic therapy;Barbazetto;Am. J. Ophthalmol.,2003

4. Ras and Rho GTPases: a family reunion;Bar-Sagi;Cell,2000

5. GAIP and RGS4 are GTPase-activating proteins for the Gi subfamily of G protein alpha subunits;Berman;Cell,1996

Cited by 479 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interaction of noncoding RNAs with hippo signaling pathway in cancer cells and cancer stem cells;Non-coding RNA Research;2024-12

2. Signalling of the neuropeptide calcitonin gene-related peptide (CGRP) through RAMP1 promotes liver fibrosis via TGFβ1/Smad2 and YAP pathways;Experimental Cell Research;2024-09

3. Anti-cancer effects of nitazoxanide in epithelial ovarian cancer in-vitro and in-vivo;Chemico-Biological Interactions;2024-09

4. Loss of the tumor suppressor NUMB drives aggressive bladder cancer through hyperactivation of a RhoA/ROCK/YAP signaling circuitry;2024-08-28

5. Targeting the Hippo- Yes-Associated Protein/Transcriptional Coactivator with PDZ-Binding Motif Signaling Pathway in Primary Liver Cancer Therapy;Onco;2024-08-22